ARB+diurites vs ARB+Ca blocker.

Trial Profile

ARB+diurites vs ARB+Ca blocker.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 29 May 2015

At a glance

  • Drugs Amlodipine; Hydrochlorothiazide; Telmisartan
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms TAT Kobe
  • Most Recent Events

    • 27 May 2015 Status changed from recruiting to active, no longer recruiting as per University Hospital Medical Information Network - Japan record.
    • 28 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top